Journal
CANCER GENOMICS & PROTEOMICS
Volume 14, Issue 2, Pages 103-117Publisher
INT INST ANTICANCER RESEARCH
DOI: 10.21873/cgp.20023
Keywords
Malignant mesothelioma; proteomics; iTRAQ; secretome
Categories
Funding
- National Health and Medical Research Council of Australia [1063067]
- National Health and Medical Research Council of Australia [1063067] Funding Source: NHMRC
Ask authors/readers for more resources
Backgound/Aim: Malignant mesothelioma (MM) is an aggressive and fatal pleural cancer. The cell secretome offers information allowing insight into the pathogenesis of MM while offering the possibility to identify potential therapeutic targets and biomarkers. In the present study the secretome protein profile of MM cell lines was compared to normal mesothelial cells. Materials and Methods: Six MM cell lines were compared against three primary mesothelial cell culture preparations using iTRAQ (R) mass spectrometry. Results: MM cell lines more abundantly secreted exosome-associated proteins than mesothelial cells. MM cell secretomes were enriched in proteins that are involved in response to stress, carbon metabolism, biosynthesis of amino acids, antigen processing and presentation and protein processing in the endoplasmic reticulum. Conclusion: The MM cell secretome is enriched in proteins that are likely to enhance its growth and response to stress and help it inhibit an adaptive immune response. These are potential targets for therapeutic and biomarker discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available